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ABSTRACT: MHC class II molecules bind peptides derived from extracellular proteins
that have been ingested by antigen-presenting cells and display them to the immune
system. Peptide loading occurs within the antigen-presenting cell and is facilitated by
HLA-DM. HLA-DM stabilizes the open conformation of the MHCII binding groove
when no peptide is bound. While a structure of the MHCII/HLA-DM complex exists,
the mechanism of stabilization is still largely unknown. Here, we applied customized
Natural Move Monte Carlo to investigate this interaction. We found a possible long-
range mechanism that implicates the conﬁguration of the membrane-proximal globular
domains in stabilizing the open state of the empty MHCII binding groove.
■ INTRODUCTION
The MHC class II complex (MHCII) presents potentially
harmful peptides to the immune system.1 The structure of the
peptide-loaded MHCII binding groove is well documented.2
However, due to its dynamic and unstable nature no structure
has been solved for the peptide-free MHCII complex to date;3
when peptide is absent, MHCII complexes rapidly take on an
inactive peptide-averse state.4 The peptide-exchange factor
human leukocyte antigen DM (HLA-DM) is known to
stabilize the empty MHCII complex5 and promote a peptide-
receptive state.6 A structure of HLA-DM in complex with
MHCII has been published;7 however, the mechanism by
which HLA-DM stabilizes the peptide-receptive state of the
MHCII binding groove is still a subject of debate.8
Given that one of the key binding sites for HLA-DM on
MHCII includes the β2 globular subunit7,9 and that antibodies
detect peptide-induced structural changes in the β2 globular
subunit,10 it was suggested that the HLA-DM chaperoning
mechanism involves the long-range transmission of structural
changes from the globular subunits to the binding groove
(Figure 1).11 The hypothesis states that HLA-DM binding
causes structural changes in the membrane-proximal β2
subunit of MHCII that can be propagated to the binding
groove to modulate peptide binding.10
We evaluated this experimentally suggested hypothesis and
investigated the underpinning mechanistic details of the HLA-
DM/MHCII (without peptide) interaction with customized
Natural Move Monte Carlo (cNMMC).12 cNMMC is a
protocol for hypothesis based modeling using Natural Move
Monte Carlo (NMMC),13 an established molecular simulation
method that has been applied to investigate several biophysical
research questions including receptor signaling,14 prediction of
nucleosome occupancy,15 energy contributions of epigenetic
DNA marks,16 RNA mutations,17 and reﬁnement of projection
images.18 Importantly, NMMC has previously been validated
on the MHC class I complex. Coarse-grained NMMC
simulations, using a knowledge potential, showed high
agreement with experimental results (AROC = 0.85) in the
prediction of peptide binders and nonbinders.19
Our results suggest that conformational shifts in the MHCII
globular domains enable a larger range of motion in the two α-
helices lining the binding groove, thereby increasing the
likelihood of binding-groove collapse and occlusion of peptide
binding. In follow-up simulations we show that the peptide-
chaperoning protein HLA-DM stabilizes the interaction
between the two MHCII globular domains, thereby promoting
the open state of the empty binding groove via an indirect
long-range mechanism.
■ RESULTS
The Eﬀect of HLA-DM on the MHCII Binding Groove.
HLA-DM is known to catalyze the peptide exchange in MHCII
molecules. It binds laterally to the α1 region in the binding site
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and the α2 and β2 globular domains (+DM in Figure 2A) and
stabilizes the peptide-receptive form of the MHCII. The
structural mechanism by which this stabilization occurs is
largely unknown.
Based on the experimentally suggested hypothesis (Figure
1), we designed a set of customized Natural Moves to
investigate a potential involvement of the MHCII globular
domains in the stabilization of the binding groove. In a
previous study we identiﬁed a set of NMMC parameters that
led to the collapse of the binding groove largely driven by the
plasticity of the β1-1 kink in the β1 helix.12 Here, we used the
same structure (PDB accession code: 4GBX - MHCII in
complex with HLA-DM) and NMMC parameters as a starting
point for investigating the mechanism underlying MHCII
binding-groove stabilization. First, we simulated the collapse of
the binding groove by performing simulations in the absence of
HLA-DM. In a second set of simulations, we used the same
parameters and added the peptide-loading chaperone HLA-
DM to test its eﬀect on the stability of the binding groove.
While the simulation without HLA-DM (-DM) showed a well-
deﬁned bimodal distribution of binding-groove widths
indicating the potential for a collapse (leading to a peptide-
averse state), the simulation with HLA-DM (+DM) resulted in
a single mode around the open state of the binding groove
(Figure 2C). Furthermore, the movement of the MHCII
globular domains was restricted by HLA-DM (Figure S1).
Figure 1. Schematic showing hypothesis of HLA-DM assisted MHC
class II binding-groove stabilization. HLA-DM (blue) binds laterally
to the N-terminal side of the α1 helix and the two globular domains
(α2 and β2 in surface representation) of MHC class II (chains A and
B in dark and light gray, respectively). The experimentally suggested
hypothesis states that HLA-DM acts through a long-range
mechanism, stabilizing the MHCII binding groove via the globular
domains.
Figure 2. HLA-DM stabilizes the open MHCII binding-groove conﬁguration indirectly through the globular domains. A. -DM: The two globular
domains were allowed to move independently from each other. The xyz coordinate and rotation arrows indicate independent translation and
rotation; -DM*: The -DM data set excluding structures with detached globular domains. The grayed out structures indicate MHCII complexes with
compact globular domains, which were excluded from this data set. The structures with accompanying arrows showing detached globular domains
indicate the types of conﬁrmations that were included in the data set; -DM**: The two globular domains were propagated as a rigid body unit. The
xyz coordinate and rotation arrow together with the lock indicate joint movement; +DM: Simulation with independently moving globular domains
in the presence of HLA-DM. The MHCII complex is depicted in gray (chains A and B in light and dark gray, respectively) and HLA-DM in blue.
The membrane-distal α1 and β1 domains are shown in cartoon, and the globular domains α2 and β2 are shown in surface representation. B. Top
view of the MHCII binding groove. The two-headed arrow indicates the position at which the binding-groove width was measured, and the single-
headed arrow shows the β1-1 kink. C. Distributions of binding-groove widths. The solid green line shows data for simulations in the absence of
HLA-DM (-DM), revealing a bimodal distribution. The dashed orange line shows a subset of the -DM data set ﬁltered for states with compact
globular domains (-DM*). The dashed purple and pink lines show the results for simulations where the globular domains were moved as a rigid
body unit (-DM**) and where HLA-DM was present (+DM), respectively.
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To test whether the conﬁguration of the globular domains
was linked to the plasticity of the binding groove, we generated
a subset of the original simulation trajectories without HLA-
DM (-DM) that excluded states with globular domains that
had separated from each other and the binding groove
(distance between centers of mass of globular domains α2 and
β2 ≥ 26 Å and nearest distance between the binding groove
and the globular domain ≥6 Å) (-DM*). These cutoﬀs were
chosen based on the distance distributions observed during
simulation (Figure S2). Figure S3 shows the distance between
the binding groove and the globular domain that was
measured. Interestingly, the resulting conditional distribution
matched the binding-groove width distribution seen in the
simulation where HLA-DM was present (+DM in Figure 2C).
To conﬁrm this result, we designed a customized Natural
Move simulation in which the two globular domains α2 and β2
were grouped (using original positions observed in the crystal
structure) -DM**, thereby eﬀectively preventing the separation
of the globular domains throughout the simulation (unlike in
the -DM simulation, where the globular domains were allowed
to move independently). Grouping the globular domains was
suﬃcient to prevent the collapse of the binding groove in the
absence of HLA-DM as shown by the -DM** distribution in
Figure 2C. The results closely matched the distributions of the
simulation where HLA-DM was bound (+DM) and the subset
of the simulation with freely moving globular domains that
only included interacting globular domains (-DM*).
Figure 3 shows that the eﬀect we discovered cannot be
traced back to a simple interaction between the top or bottom
part of HLA-DM and MHCII. The complete structure of
HLA-DM is required for the stabilizing eﬀect to be seen. Note
that the globular domains of MHCII are less mobile in the
presence of the bottom part of HLA-DM than in the presence
of the top part of HLA-DM. However, neither fully restricts
the movement of the MHCII globular domains in our
simulations; this only happens in the presence of the full
HLA-DM structure. Note, we ran initial simulations of the
MHCII/HLA-DM complex with a mutated residue in the β-
chain globular domain (B:V186K), and while binding of the
globular domain was aﬀected, the eﬀect was not suﬃcient to
reproduce the binding-groove collapse (data not shown). A
more detailed visualization of the HLA-DM/MHCII complex
is shown in Figure S4.
This suggests a long-range mechanism that implicates the
role of the MHCII globular domains in the modulation of the
MHCII binding groove (Figure 4). When the peptide-loading
chaperone HLA-DM is bound, the MHCII globular domains
are kept in a compact conﬁguration, and the binding groove
remains in an open state. In the absence of HLA-DM, the
MHCII globular domains are free to move, which allows
increased movement of the β1 helix leading to an increased
collapse of the binding groove.
We tested the hypothesis that binding-groove plasticity may
be linked to the conﬁguration of the globular domains. We
performed the following simulations: 1. Simulation of MHCII
in the absence of HLA-DM with independently moving
globular domains; 2. Simulation of MHCII in the presence of
HLA-DM with independently moving globular domains; and
3. Customized Natural Move simulations of MHCII in the
absence of HLA-DM, in which the globular domains were
propagated as a uniﬁed segment.
In our initial simulations without HLA-DM and independ-
ently moving globular domains, the globular domains regularly
visited structural states, which showed increased occurrence of
a narrowed binding groove and coincidentally separated
globular domains. We used customized Natural Moves to
investigate the importance of the globular domains in the
collapse of the binding groove. Using cNMMC, we propagated
the globular domains collectively rather than independently,
which prevented globular domain separation and binding-
groove collapse. When the simulation with independent
globular domains (and no HLA-DM) was ﬁltered for states
with compact globular domains, the proportion of open
binding-groove states was also signiﬁcantly increased, suggest-
ing a dependency between the conﬁguration of the globular
domains and the conformational state of the binding groove.
Figure 3. Full HLA-DM structure is required for MHCII stabilization.
The MHCII binding-groove width distribution during simulation of
MHCII in complex with various parts of HLA-DM (no DM, top +
bottom DM, top DM, bottom DM) is shown.
Figure 4. Proposed HLA-DM mechanism. Without HLA-DM, the
globular domains of the HLA-DR (MHCII) complex take on a less
compact conﬁguration, loosening the connecting loop to the binding
groove, thereby allowing the β1 helix to collapse. In the presence of
HLA-DM, the MHCII globular domains remain in a compact
conﬁguration, applying a pulling force on the loop connecting the β2
globular domain and the β1 helix, thereby preventing binding-groove
collapse.
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■ DISCUSSION
The experimental observations from the literature together
with our results suggest a mechanism where, in the absence of
HLA-DM, the MHCII globular domains change conformation,
resulting in a long-range eﬀect which causes the binding groove
to collapse. Speciﬁcally, it seems that the β1-1 kink on the β1
helix plays a major role in this plasticity. HLA-DM prevents
this collapse indirectly by restraining the globular domains in a
compact conformation and thereby stiﬀening the β1 helix and
stabilizing the open binding groove.
In our simulations we found that HLA-DM modulates the
receptiveness of the MHC binding groove indirectly via a
necessary contact to the globular α2/β2 regions of the MHC.
This ﬁnding is supported by several lines of experimental
evidence. Carven et al. have used chemical labeling and mass
spectrometry to characterize residues that are involved in
peptide-induced conﬁgurational changes in the globular
domains.20 Furthermore, studies comparing MHCII crystal
structures have shown conformational diversity in the globular
domains, speciﬁcally rigid body motions of the β2 domain of
up to 15 degrees.21,22
HLA-DM binds MHCII laterally, with the main interaction
sites being at the N-terminal side of the α1 helix and on the
two globular domains,7 distal from the structurally labile β1
helix.20
Several groups have observed increased structural movement
in the β1 helix in simulations of empty MHCII mole-
cules.10−12,22,23 The question arises how HLA-DM may
counteract this structural lability if its binding site is on the
opposite of the MHCII molecule.
In 2004, Carven et al. generated four antibodies that
detected peptide-induced structural changes. Three of these
conformation-sensitive antibodies bound to an epitope on the
β1 helix (β53-67), and the fourth antibody, MEM-266, bound
to the last ﬁve residues on the β2 globular subunit.10 As the
most important epitope residues are positioned in a linear
contiguous fashion and similar MEM-266 aﬃnities were
observed for the empty protein and the corresponding epitope
peptides, it was suggested that the epitope was nonconforma-
tional. Therefore, selective antibody binding was most likely
regulated by conﬁgurational changes of the globular domains
rather than local residue rearrangements.
In 2000, before the ﬁrst MHCII/HLA-DM structure was
published, Doebele et al. found a set of residues on MHC that,
if mutated, led to the disruption of DM activity. Among this set
was a mutation in the β2 globular domain (V186 K), which is
distant from the binding groove and is one of the sites that
make up the epitope region for MEM-266.
Given this evidence Carven et al. suggested a HLA-DM
chaperoning mechanism involving the long-range transmission
of structural changes from the globular subunits to the binding
groove. Speciﬁcally, they proposed that HLA-DM binding
causes structural changes in the membrane-proximal β2
subunit of MHCII that is propagated to the binding groove
to modulate peptide binding.10
The results presented in this study, that is the stabilization of
the MHCII binding groove via a long-range interaction
involving the globular domains of both MHCII and HLA-
DM, corroborate the observations described above. Further-
more, our results point toward a mechanism that could explain
how the stabilization takes place despite the main site of
interaction between HLA-DM and MHCII being at the
opposite end of the labile MHCII β-chain helix.
■ CONCLUSION
The biophysical mechanism, by which HLA-DM stabilizes the
peptide-receptive state of the MHCII binding groove, is a
subject of debate. Experimental results in the literature suggest
that the mechanism involves long-range structural changes that
propagate from the membrane-proximal globular subunits to
the membrane-distal binding groove. In our Natural Move
Monte Carlo simulations we were able to reproduce the
MHCII binding-groove stabilization by HLA-DM. By running
simulations with various structural parts of HLA-DM, we have
found that neither the globular domains nor the membrane-
distal part that interacts with the MHCII binding groove
stabilizes the MHCII binding groove in isolation. The full
HLA-DM structure was required to stabilize the MHCII
globular domains and by extension the MHCII binding groove.
This result corroborates existing hypotheses about the
nonintuitive stabilization of the peptide-receptive state of the
MHCII binding groove.
■ METHODS
Natural Move Monte Carlo. In Natural Move Monte
Carlo (NMMC), the system is decomposed into a priori
deﬁned structural segments or groups of segments, which are
called regions. The set of residues that are not part of segments
constitutes the molten zones. Within the current model (see
below) a molten zone is a continuous set of coarse-grained
residues connecting adjacent segments of the same molecular
chain.
Formally, all degrees of freedom, X, are partitioned into
independent (Xi) and dependent (Xd) degrees of freedom
(DoF). Here, Xi represents independent translational and
orientational arrangement of structural segments or regions
(groups of segments). In addition, Xi also contains the internal
DoFs of segments, such as torsional and bond angles. The
independent motion of segments (e.g., within one chain) may
lead to chain breaks, which are repaired using a chain closure
algorithm24 that adjusts the position of coarse-grained centers
of molten zone residues by changing corresponding torsional
and bond angles, which are the dependent DoFs, Xd. In this
way Xd are instantaneously adjusted (following each proposed
change in Xi) to facilitate exploration along Xi and
simultaneously preserve the integrity of the molecular chain(s)
through chain closure(s).
The basic principle is that each new conﬁguration during a
proposal step is obtained via a combined chain breakage
closure algorithm. This composite proposal kernel includes a
stochastic proposal to update Xi followed by ﬁnding an optimal
(with respect to the new Xi) arrangement along Xd so that all
chain breaks are repaired. More details about the method can
be found in the following publication.24
For the current model used, the exact deﬁnition of
independent Xi and dependent Xd degrees of freedom is
described in detail.24 In addition, we provide an online tutorial
with movies (www.cs.ox.ac.uk/mosaics) that illustrates the
independent degrees of freedom in each simulation.
Note that the algorithm aims to sample the conformational
space along user deﬁned independent degrees of freedom as
described in ref 12. Given this initial choice, the method
generates canonical distributions over an eﬀective energy
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surface. Since the proposal kernel is symmetrical, we use
classical Metropolis Monte Carlo, which satisﬁes detailed
balance, to sample the diﬀerent states.
Customized Natural Move Monte Carlo. Traditionally
NMMC is used to explore the conformational landscape along
a particular set of degrees of freedom chosen by the researcher.
However, the initial choice of degrees of freedom might not
always be optimal. Additionally, if the objective is to investigate
the causality of functional motions, it may be informative to
perform NMMC simulations for a variety of sets of degrees of
freedom. NMMC allows for the modulation of translations and
rotations of segments as well as torsion and bend angles of
bonds. Thus, users can compare diﬀerent sets of customized
Natural Move Monte Carlo (cNMMC) simulations to infer
causal relationships in functional motions. cNMMC was
introduced in ref 12 as a practical framework for systematically
designing a set of said simulations that together are targeted at
probing a speciﬁc biological question. In this way the cNMMC
approach entails an ensemble of NMMC simulations each with
a unique set of degrees of freedom aimed at testing a speciﬁc
hypothesis.
Practical Implementation of the Decomposition.
Natural Move Monte Carlo requires the decomposition of
the structure into segments and ﬂanking molten zones. The
segments are propagated at each MC iteration, and the molten
zones serve to close the chain break. Thus, the molten zones
represent labile areas in the structure and should be carefully
chosen. In the MHCII structure, residues β53-68 on helix β1
are part of epitopes for conformation-sensitive antibodies that
are selective for the empty binding groove.10,25 This region has
been shown to undergo local structural changes by CD
spectroscopy.10 MD simulations and comparison of exper-
imental MHCII structures revealed structural variability
around a sharp kink in this region.11,22,23 Furthermore, we
have shown using customized Nature Moves that this region
contributes largely to the collapse of the binding groove. Given
these observations, we introduced a molten zone at the N-
terminal kink of the β1 helix (β1-1 in Figure 2B), as well as at
the regions ﬂanking the β1 helix.
The Model. The coarse-grained model has three centers
per residue. For each residue, the three atoms chosen are the
C, the carbonyl oxygen, and a single side-chain atom that is the
closest to the center of mass of the side chain. The three center
per residue model inherits an interaction potential from
previous work, a carefully parametrized knowledge-based
interaction potential26 trained on 4500 known protein
structures. Our model (the current three center per residue
model combined with the above interaction potential) has
been benchmarked to reliably describe the nativelike properties
of most known protein folds.27
Our knowledge-based potential (similar to most statistical
potentials trained on experimental structures) implicitly
incorporates the eﬀects of solvent. Furthermore, the current
model (3-point per residue coarse-grained description
combined with the above-mentioned knowledge-based inter-
action potential) has been shown to reproduce functionally
relevant and often experimentally seen molecular motions in
several applications on systems including molecular chaper-
onines,18 diabodies,14 and even MHC complexes.12,19
Simulation Details. All simulations were carried out with
the MOSAICS software package.28 All distributions were
plotted with matplotlib29 and pandas30 using a bandwidth of
0.1. NMMC simulations were initiated from an X-ray structure
of HLA-DR (MHCII) in complex with HLA-DM at a
resolution of 2.6 Å (PDB: 4GBX).7 The peptide was removed,
and the MHCII/HLA-DM complex was equilibrated for
10,000 steps at 300 K. The structures were coarse-grained
using a 3-point per residue protein model.27 The MHCII
model was generated by removing the HLA-DM part of the
structure ﬁle and equilibrating for a further 10,000 iterations at
300 K. In order to ensure extensive conformational sampling,
we performed Parallel Tempering using six replicas at
temperatures 300, 336, 376, 421, 472, and 529 K. We ran 15
independent repeats for each test case. Each repeat was run for
6 × 1,000,000 Monte Carlo iterations each, and the replica
exchange rate was 0.1. The average acceptance rate within
replicas was 0.5 and 0.3 for MHCII and MHCII/HLA-DM
simulations, respectively. The average acceptance rate for
jumps between replicas was 0.16. All data were collected at a
canonical temperature of 300 K. The average run time per
simulation was 16 h (1 h equilibration, 15 h production) using
individual Intel E5-2640v3 Haswell cores on the ARC Oxford
Supercomputer. Distances were calculated with MDAnalysis.31
Structural Distances. In the analysis of our simulations we
deﬁne the binding-groove width as the distance between the
centers of mass of residues chain A:60-65 and chain B:65-70
(as deﬁned by Kumar et al.32). The distances between the two
globular domains α2 (A:84-182) and β2 (B:95-190) were
calculated between the residues closest to their respective
centers of mass. The distance between globular domain β2 and
the binding groove was calculated between the two residues on
chain A and chain B that were closest in the starting structure
(A:29 and B:151, see Figure S3).
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